Trial Profile
Comparative Effects of Anti-diabetic Medications on Postprandial Hyperlipidaemia, Free Fatty Acid Signaling, and Endothelial Dysfunction in Individuals With Prediabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Saxagliptin (Primary)
- Indications Metabolic disorders; Prediabetic state
- Focus Pharmacodynamics
- 26 Jun 2018 Results presented at the 78th Annual Scientific Sessions of the American Diabetes Association
- 04 May 2017 Status changed from recruiting to completed.
- 30 Jun 2014 New trial record